Publications

4674 Results

Pediatric clinical trials with hydroxyurea (NSC-30265).

Authors
DJ Fernbach
Journal / Conference
Cancer Chemotherapy Reports 40:37-38
Year
1964

Studies on a metabolic defect induced by hydroxyurea (NSC-30265).

Authors
EP Frenkel;WN Skinner;JD Smiley
Journal / Conference
Cancer Chemotherapy Reports 40:19-22
Year
1964

Hydroxyurea (NSC-32065): Results of a Phase I study.

Authors
KM Griffith
Journal / Conference
Cancer Chemotherapy Reports 40:33-36
Year
1964

Vincristine (NSC-67574) in uncommon malignant disease in children.

Authors
TB Haddy;DJ Fernbach;WL Watkins;MP Sullivan;J Windmiller
Journal / Conference
Cancer Chemotherapy Reports 41: 41-45
Year
1964

Cyclophosphamide (NSC-26271) in uncommon malignant neoplasms in children.

Authors
TM Holcomb;ME Haggard;J Windmiller
Journal / Conference
Cancer Chemotherapy Reports 36:73-75
Year
1964

Phase II studies of hydroxyurea (NSC-32065) in adults: Clinical evaluation.

Authors
IH Krakoff;H Savel;ML Murphy
Journal / Conference
Cancer Chemotherapy Reports 40:53-55
Year
1964

Preliminary survey of hydroxyurea (NSC-32065) as a teratogen.

Authors
ML Murphy;S Chaube
Journal / Conference
Cancer Chemotherapy Reports 40:1-7
Year
1964

Erythema in areas of previous irradiation in patients treated with hydroxyurea (NSC-32065).

Authors
ME Sears
Journal / Conference
Cancer Chemotherapy Reports 40:31-32
Year
1964

Cyclophosphamide therapy in childhood neuroblastoma.

Authors
WG Thurman;DJ Fernbach;MP Sullivan
Journal / Conference
N England J Med 270:1336-1340
Year
1964
Research Committee(s)
Brain

Study of serum B12 and folate in patients treated with hydroxyurea (NSC-32065).

Authors
WG Thurman;WL Watkins
Journal / Conference
Cancer Chemotherapy Reports 40:23-25
Year
1964